Becton Dickinson ramps upsyringe production amid demanddriven by China quality concerns

Becton Dickinson ramps upsyringe production amid demanddriven by China quality concerns

BD’s North Canaan plant has increased its output of syringes by more than 40% to meet the needs of U.S. healthcare customers after the FDA launched an ongoing investigation into quality issues with plastic syringes made in China.

Provided

NORTH CANAAN, Conn. — Becton, Dickinson and Company (BD) has ramped up its production of syringes at its North Canaan plant in response to quality issues with plastic syringes imported from China which were uncovered late last year by the U.S. Food and Drug Administration (FDA).

BD, a leading global medical technology company and Northwest Connecticut’s largest employer, responded to the FDA’s recommendation that consumers, healthcare providers and healthcare facilities transition away from plastic syringes made in China by increasing its domestic manufacturing of syringes at the company’s Connecticut and Nebraska facilities.

Since January, BD’s 385,000-square-foot North Canaan plant has increased its output of syringes “by over 40% to meet the needs of U.S. healthcare customers,” according to Fallon McLoughlin, director of public relations and corporate communications for the Franklin Lakes, N.J.-based company.

“BD has achieved this increase by driving operational efficiencies and relocating some production lines from other BD plants,” said McLoughin.

“We’ve added over 100 full-time associates in the last year, and currently have more than 500 full-time associates and nearly 50 contingent associates,” she said of the North Canaan site, which began its operations in 1961 with eight employees at a 25,000-square-foot facility.

BD draws its employees from throughout Northwest Connecticut and neighboring New York.

McLaughlin noted that its Connecticut plant primarily manufactures small-size syringes, and syringe and needle combination products that are “critical to the delivery of healthcare.”

Operations take place around the clock, producing more than 2 billion medical devices each year that are sold in every region worldwide.

Responding to consumer needs

In March, Eric Borin, president of BD Medication Delivery Solutions, announced a statement saying: “BD has the capacity to support additional syringe demand and is further increasing U.S. production to help ensure continuity of patient care.”

Since the initial FDA safety communication in November 2023, he noted, “BD has increased domestic manufacturing of syringes in our Nebraska and Connecticut facilities to respond to customer needs. Ensuring the safety and quality of our products is the top priority at BD.”

Borin further noted at the time that “The latest FDA safety communication does not include any BD syringes. Over our more than 125-year history, we have served the health care system’s need for essential high quality medical products, including manufacturing 2 billion additional syringes and needles to support the global pandemic response to COVID-19.”

Syringe manufacturers in China cited

In late November 2023, the FDA announced its probe into reports of leaks, breakages and other quality problems with plastic syringes manufactured in China “that are used for injecting fluids into or withdrawing fluids from, the body,” according to the health regulator.

On March 14, the FDA issued an update on warning letters sent to three entities: Jiangsu Shenli Medical Production Co. Ltd, Medline Industries, LP and Sol-Millennium Medical Inc., describing violations related to the “sale and distribution of unauthorized plastic syringes that had not been cleared or approved by the FDA,” according to a new release.

“In addition, we are actively evaluating quality issues and performance testing failures with plastic syringes made by Jiangsu Caina Medical Co Ltd., a China-based manufacturer sited in the warning letter issued to Medline Industries, LP. The FDA will take additional steps as appropriate,” the FDA stated.

In its August 16 update, the FDA continued to recommend that healthcare providers “use syringes not manufactured in China, if possible.

“At this time, glass syringes, pre-filled syringes or syringes used for topical purposes are not included. If you only have syringes manufactured in China, then continue to use them as needed until you are able to use alternative syringes and closely monitor for leaks, breakage and other problems,” the FDA announced.

In March, BD was named to Fortune’s 2024 list of America’s Most Innovative Companies, and in September, the company announced that it had been named to TIME’s 2024 list of the World’s Best Companies based on employee feedback.

BD’s operations in North Canaan have also been recognized by the U.S. Environmental Protection Agency for achieving the Energy Star Challenge for Industry for energy reduction. The site is a landfill-free site where waste is reduced, recycled or converted into energy.

Latest News

Fallen trees injure man, destroy fences at dog shelter

Two uprooted locust trees still lie in the yard in front of Animal Farm Foundation’s original kennels where they fell on a fence during a storm on Thursday, June 19.

Nathan Miller

AMENIA — Fallen trees, uprooted and splintered during a thunderstorm, injured a man, destroyed fences and damaged a dog kennel at the Animal Farm Foundation facilities in Bangall.

Isaias Nunez was cleaning along a road on the property with Marco Ortiz, another employee of the dog shelter, when the storm rolled in on the afternoon of Thursday, June 19.

Keep ReadingShow less
Siglio Press: Uncommon books at the intersection of art and literature

Uncommon books at the intersection of art and literature.

Richard Kraft

Siglio Press is a small, independent publishing house based in Egremont, Massachusetts, known for producing “uncommon books at the intersection of art and literature.” Founded and run by editor and publisher Lisa Pearson, Siglio has, since 2008, designed books that challenge conventions of both form and content.

A visit to Pearson’s airy studio suggests uncommon work, to be sure. Each of four very large tables were covered with what looked to be thousands of miniature squares of inkjet-printed, kaleidoscopically colored pieces of paper. Another table was covered with dozens of book/illustration-size, abstracted images of deer, made up of colored dots. For the enchanted and the mystified, Pearson kindly explained that these pieces were to be collaged together as artworks by the artist Richard Kraft (a frequent contributor to the Siglio Press and Pearson’s husband). The works would be accompanied by writings by two poets, Elizabeth Zuba and Monica Torre, in an as-yet-to-be-named book, inspired by a found copy of a worn French children’s book from the 1930s called “Robin de Bois” (Robin Hood).

Keep ReadingShow less
Cycling season: A roundup of our region’s rentals and where to ride them

Cyclists head south on the rail trail from Copake Falls.

Alec Linden

After a shaky start, summer has well and truly descended upon the Litchfield, Berkshire and Taconic hills, and there is no better way to get out and enjoy long-awaited good weather than on two wheels. Below, find a brief guide for those who feel the pull of the rail trail, but have yet to purchase their own ten-speed. Temporary rides are available in the tri-corner region, and their purveyors are eager to get residents of all ages, abilities and inclinations out into the open road (or bike path).

For those lucky enough to already possess their own bike, perhaps the routes described will inspire a new way to spend a Sunday afternoon. For more, visit millertonnews.com/tag/bike-route to check out two ride-guides from local cyclists that will appeal to enthusiasts of many levels looking for a varied trip through the region’s stunning summer scenery.

Keep ReadingShow less